• Home
  •  / VentiRx Pharmaceuticals
ProfileJobs

VentiRx Pharmaceuticals

Suggest Edit
Healthcarebiotechdrug developmentpharma
VentiRx Pharmaceuticals is a clinical stage biopharmaceutical company, engages in the development and commercialization of medicines for the treatment of cancer, and respiratory and autoimmune diseases. The company focuses on the development of small molecule product candidates targeting toll-like receptor 8 (TLR8) agonists and antagonists. Its product pipeline comprises VTX-2337, a small molecule TLR8 agonist that stimulates myeloid dendritic cells and monocytes, and enhances natural killer cell responses for the treatment of solid tumors, ovarian and breast cancers, and NHL and SCHN; VTX-1463, a stand alone agent for the treatment of seasonal and perennial allergies; TLR8 antagonists for the treatment of autoimmune diseases; and multiple compounds that are treated as vaccine adjuvants.
StateClosed
TypeSubsidiary
Parent CompanyCelgene
HQSeattle, WA, US
Founded2006
Websiteventirx.com
Cybersecurity ratingBMore
VentiRx Pharmaceuticals was founded in 2006 and is headquartered in Seattle, WA, US

Viewing summary data as a guest

Sign up for free to see all data
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at VentiRx Pharmaceuticals

Robert Hershberg

Robert Hershberg

CEO & Board Member
James Kyle Bryan

James Kyle Bryan

Chief Medical Officer
Kathleen Fanning

Kathleen Fanning

VP, Business Development & Alliance Management
Michael J. Kamdar

Michael J. Kamdar

Co - Founder
Tressa D. Randall

Tressa D. Randall

VP, Regulatory Affairs
Maura Ann Matthews

Maura Ann Matthews

Director, Product Development
Show more

VentiRx Pharmaceuticals Office Locations

VentiRx Pharmaceuticals has an office in Seattle
Seattle, WA, US (HQ)
1191 2nd Ave
Show all (1)

VentiRx Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2006

Total Funding

$104.5 m

Investors

MedImmune Ventures, Frazier Healthcare Partners
In total, VentiRx Pharmaceuticals had raised $104.5 m. VentiRx Pharmaceuticals is a subsidiary of Celgene

VentiRx Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

Learn more about our premium products
SecurityScorecard logo

VentiRx Pharmaceuticals Online and Social Media Presence

VentiRx Pharmaceuticals's Trends

Embed Graph

VentiRx Pharmaceuticals Blogs

October 29, 2019

Light The Night: How To Organize 1 Million People to Fight Blood Cancer

If you are going to fight a battle, then you need an army—especially when you are up against a ruthless opponent like blood cancer, which is expected to take an estimated 56,770 lives in the United States this year alone. … Continue reading → The post Light The Night: How To Organize 1 Million Peopl…
September 12, 2019

Understanding the Complexities of a Myelofibrosis Diagnosis

Someone who’s just been diagnosed with myelofibrosis may feel like they stepped onto a rollercoaster with little control over what comes next. With little warning, the common symptoms of this rare blood cancer – such as fatigue, stomach pain and … Continue reading → The post Understanding the Comple…
September 12, 2019

Get To Know JAK2 and Its Role in Myelofibrosis

For researchers studying myelofibrosis, the JAK protein family doesn’t live up to its original name. Initially nicknamed “Just Another Kinase,” the Janus Kinase 2 protein has recently been identified as one of the key players in myelofibrosis, a cancer in … Continue reading → The post Get To Know JA…
September 09, 2019

Care Partners Offer Critical Insights into Cognitive Symptoms of Multiple Sclerosis

Even before Nicole Lemelle was diagnosed with multiple sclerosis (MS) at the age of 25, her now-husband, Tommy, had already noticed a decline in her physical abilities and vision. Eventually he started to notice her cognitive decline. She would get … Continue reading → The post Care Partners Offer C…

 VentiRx Pharmaceuticals Frequently Asked Questions

  • When was VentiRx Pharmaceuticals founded?

    VentiRx Pharmaceuticals was founded in 2006.

  • Who are VentiRx Pharmaceuticals key executives?

    VentiRx Pharmaceuticals's key executives are Robert Hershberg, James Kyle Bryan and Kathleen Fanning.

  • How many employees does VentiRx Pharmaceuticals have?

    VentiRx Pharmaceuticals has 15 employees.

  • Who are VentiRx Pharmaceuticals competitors?

    Competitors of VentiRx Pharmaceuticals include Livzon Pharmaceutical Group, PPD and Alembic Pharmaceuticals.

  • Where is VentiRx Pharmaceuticals headquarters?

    VentiRx Pharmaceuticals headquarters is located at 1191 2nd Ave, Seattle.

  • Where are VentiRx Pharmaceuticals offices?

    VentiRx Pharmaceuticals has an office in Seattle.

  • How many offices does VentiRx Pharmaceuticals have?

    VentiRx Pharmaceuticals has 1 office.